European Life Science Tools and Reagents Market: Strategies for Growth and Innovation
26. November 2024 12:34 ET
|
BCC Research LLC
Boston, Nov. 26, 2024 (GLOBE NEWSWIRE) -- “According to the latest study from Research, “European Life Science Tools and Reagents Market,” the market for COVID-19 diagnostics products was $14.7...
Integra LifeSciences Opens New Center of Innovation and Learning
11. Mai 2023 16:30 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, hosted a ribbon-cutting ceremony on Thursday,...
Misonix Appoints Patrick J. Beyer to Board of Directors
14. Mai 2021 08:30 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 14, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix Reports Fiscal 2021 Third Quarter Financial Results
06. Mai 2021 16:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix to Report Fiscal 2021 Third Quarter Financial Results and Host Conference Call and Webcast on May 6
20. April 2021 08:15 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., April 20, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix to Participate at Upcoming Investor Conferences
11. Februar 2021 10:00 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix Reports Fiscal 2021 Second Quarter Financial Results
04. Februar 2021 16:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix to Report Fiscal 2021 Second Quarter Financial Results and Host Conference Call and Webcast on February 4
21. Januar 2021 10:30 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix to Report Fiscal 2020 Fourth Quarter Financial Results and Host Conference Call and Webcast on September 3
06. August 2020 08:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix to Present at the 17th Annual Craig Hallum Institutional Investor Conference On May 27
22. Mai 2020 13:00 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 22, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...